Study summary

The objective of this study is to verify the efficacy and investigate the safety of the study drug when ASP0456 is administered orally for 4 weeks and 52 weeks.

Additional Study Details

Phase
3
Product
  • linaclotide
  • Placebo
  • Type
    Interventional
    Masking
    Double (Participant, Investigator)
    Enrollment number
    186
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): Japanese
    Plain Language Summary
    Available Language(s): Japanese

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study of oral dosing of ASP0456 in Patients with Chronic Constipation? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site JP00025
      Saitama, Saitama, Japan
      Completed
      Site JP00005
      Tokyo, Tokyo, Japan
      Completed
      Site JP00003
      Tokyo, Tokyo, Japan
      Completed
      Site JP00030
      Aichi, Aichi, Japan
      Completed
      Site JP00014
      Tokyo, Tokyo, Japan
      Completed
      Site JP00037
      Hyogo, Hyogo, Japan
      Completed
      Site JP00032
      Osaka, Osaka, Japan
      Completed
      Site JP00026
      Saitama, Saitama, Japan
      Completed
      Site JP00007
      Tokyo, Tokyo, Japan
      Completed
      Site JP00010
      Tokyo, Tokyo, Japan
      Completed
      Site JP00036
      Osaka, Osaka, Japan
      Completed
      Site JP00023
      Chiba, Chiba, Japan
      Completed
      Site JP00022
      Chiba, Chiba, Japan
      Completed
      Site JP00035
      Osaka, Osaka, Japan
      Completed
      Site JP00039
      Hyogo, Hyogo, Japan
      Completed
      Site JP00031
      Osaka, Osaka, Japan
      Completed
      Site JP00027
      Saitama, Saitama, Japan
      Completed
      Site JP00013
      Tokyo, Tokyo, Japan
      Completed
      Site JP00002
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00015
      Tokyo, Tokyo, Japan
      Completed
      Site JP00001
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00019
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00034
      Osaka, Osaka, Japan
      Completed
      Site JP00024
      Chiba, Chiba, Japan
      Completed
      Site JP00021
      Chiba, Chiba, Japan
      Completed
      Site JP00008
      Tokyo, Tokyo, Japan
      Completed
      Site JP00012
      Tokyo, Tokyo, Japan
      Completed
      Site JP00028
      Saitama, Saitama, Japan
      Completed
      Site JP00020
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00018
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00011
      Tokyo, Tokyo, Japan
      Completed
      Site JP00009
      Tokyo, Tokyo, Japan
      Completed
      Site JP00029
      Aichi, Aichi, Japan
      Completed
      Site JP00038
      Hyogo, Hyogo, Japan
      Completed
      Site JP00004
      Tokyo, Tokyo, Japan
      Completed
      Site JP00017
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00040
      Fukuoka, Fukuoka, Japan
      Completed
      Site JP00033
      Osaka, Osaka, Japan
      Completed
      Site JP00006
      Tokyo, Tokyo, Japan

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?